• 1. An approach to 7-aza-1-phosphanorbornane complexes: strain promoted rearrangement of 1-iminylphosphirane complexes and cycloaddition with olefins?
  Yang Xu,Min Wang,Donghui Wei,Rongqiang Tian,Zheng Duan,Fran?ois Mathey Dalton Trans., 2019,48, 5523-5526
• 2. An apparatus for testing water by measurement of its electrical conductivity
  Analyst, 1912,37, 538-543
• 3. An integrated process of CO2 capture and in situ hydrogenation to formate using a tunable ethoxyl-functionalized amidine and Rh/bisphosphine system?
  Yu-Nong Li,Liang-Nian He,Xian-Dong Lang,Xiao-Fang Liu,Shuai Zhang RSC Adv., 2014,4, 49995-50002
• 4. An artificial photosynthesis system comprising a covalent triazine framework as an electron relay facilitator for photochemical carbon dioxide reduction?
  Siquan Zhang,Shengyao Wang,Liping Guo,Hao Chen,Bien Tan,Shangbin Jin J. Mater. Chem. C, 2020,8, 192-200
• 5. An investigation of surface properties, local elastic modulus and interaction with simulated pulmonary surfactant of surface modified inhalable voriconazole dry powders using atomic force microscopy
  Michael Kappl,Paul M. Young,Daniela Traini,Sanyog Jain RSC Adv., 2016,6, 25789-25798

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazines Halopyrimidines
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazines Pyrimidines and pyrimidine derivatives Halopyrimidines

N-Butyl-6-chloropyrimidin-4-amine: A Comprehensive Overview

The compound N-Butyl-6-chloropyrimidin-4-amine (CAS No. 26423-00-7) is a heterocyclic aromatic amine derivative with significant applications in pharmaceutical chemistry and material science. This compound has garnered attention due to its unique structural properties and potential bioactivity. In recent years, advancements in synthetic methodologies and computational modeling have shed light on its synthesis, characterization, and biological implications.

N-Butyl-6-chloropyrimidin-4-amine belongs to the class of pyrimidine derivatives, which are widely studied for their roles in nucleic acid structures and drug design. The presence of a chlorine atom at the 6-position and an N-butyl group at the 4-position introduces steric and electronic effects that influence its reactivity and solubility. These substituents also play a crucial role in modulating the compound's pharmacokinetic properties, making it a promising candidate for drug development.

Recent studies have explored the synthesis of N-butyl-pyrimidinamine derivatives using various methodologies, including microwave-assisted synthesis and catalytic cross-coupling reactions. These methods have not only improved the efficiency of synthesis but also enabled the exploration of structural analogs with enhanced bioactivity. For instance, researchers have reported the use of palladium-catalyzed coupling reactions to introduce diverse substituents onto the pyrimidine ring, leading to compounds with improved selectivity against specific biological targets.

The biological activity of N-butyl-pyrimidinamine derivatives has been extensively investigated in recent years. Preclinical studies have demonstrated their potential as inhibitors of kinase enzymes, which are key targets in cancer therapy. Additionally, these compounds have shown promise in modulating ion channels and G-protein coupled receptors (GPCRs), highlighting their versatility in addressing diverse therapeutic areas.

In terms of applications, N-butyl-pyrimidinamine derivatives are being explored for their potential in antiviral therapy. Recent research has focused on their ability to inhibit viral replication by targeting essential viral proteins or host factors. This has led to the identification of several lead compounds with potent antiviral activity, paving the way for further preclinical development.

Moreover, the environmental impact and safety profile of N-butyl-pyrimidinamine derivatives have been evaluated in accordance with regulatory guidelines. Studies indicate that these compounds exhibit low toxicity profiles under standard experimental conditions, making them suitable for further exploration in therapeutic applications.

Looking ahead, ongoing research is focused on optimizing the pharmacokinetic properties of N-butyl-pyrimidinamine derivatives through structure-based drug design. Advanced computational tools, such as molecular docking and machine learning algorithms, are being employed to predict optimal substituents that enhance bioavailability while maintaining efficacy.

In conclusion, N-butyl-pyrimidinamine derivatives represent a promising class of compounds with diverse applications in pharmaceutical chemistry. Continued research into their synthesis, biological activity, and safety profiles will undoubtedly contribute to the development of innovative therapeutic agents in the near future.

• 941294-33-3(6-chloro-N-propylpyrimidin-4-amine)
• 941294-44-6(6-Chloro-N-pentylpyrimidin-4-amine)
• 872511-30-3(6-chloro-N-ethylpyrimidin-4-amine)
• 5457-91-0(N4-butyl-6-chloropyrimidine-2,4-diamine)
• 1220028-08-9(6-chloro-N-(2-methylpropyl)pyrimidin-4-amine)
• 61667-11-6(6-Chloro-N-cyclohexylpyrimidin-4-amine)
• 941294-43-5(6-Chloro-N-cyclopropylpyrimidin-4-amine)
• 1722-14-1(4-chloro-6-(piperidin-1-yl)pyrimidine)
• 1185311-52-7(6-Chloro-N-(4-piperidinylmethyl)-4-pyrimidinamine hydrochloride)
• 89099-63-8(4-Pyrimidinamine, N-butyl-2,6-dichloro-)